LEP and metabolic dysfunction-associated steatotic liver disease: As a result, the finding that leptin and NAFLD are correlated may be useful for assessing disease risk, preventing NAFLD, combining existing therapy regimens for potentiation, and identifying prospective targets for novel drug development.